PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 63 filers reported holding PLX PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $32,000 | -72.6% | 50,261 | +3.9% | 0.00% | – |
| Q2 2022 | $117,000 | -42.6% | 48,376 | -4.6% | 0.00% | – |
| Q1 2022 | $204,000 | -31.5% | 50,684 | +36.2% | 0.00% | -100.0% |
| Q4 2021 | $298,000 | -48.2% | 37,222 | +24.9% | 0.00% | 0.0% |
| Q3 2021 | $575,000 | +145.7% | 29,801 | +75.1% | 0.00% | 0.0% |
| Q2 2021 | $234,000 | +116.7% | 17,023 | +41.9% | 0.00% | – |
| Q1 2021 | $108,000 | – | 11,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
| Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
| Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
| Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
| MBL Wealth, LLC | 52,000 | $126 | 0.03% |
| O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
| GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
| EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |